Oritavancin – an investigational glycopeptide antibiotic

Author： Ward Kristina E Mersfelder Tracey L LaPlante Kerry L

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.15, Iss.4, 2006-04, pp. : 417-429

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

From Vancomycin to Oritavancin: The Discovery and Development of a Novel Lipoglycopeptide Antibiotic

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 9, Iss. 1, 2010-01 ,pp. : 23-47

Bentham Science Publishers

Access to resources Recommend Favorite

Glycopeptide resistance in multiple antibiotic-resistant Gram-positive bacteria: a current challenge for novel semi-synthetic glycopeptide derivatives

By Malabarba A. Nicas T. Ciabatti R.

European Journal of Medicinal Chemistry, Vol. 32, Iss. 6, 1997-06 ,pp. : 459-478

Elsevier

Access to resources Recommend Favorite

Glycopeptide antibiotic analogs efficient against vancomycin-resistant bacteria: a patent evaluation (WO2013022763)

By Olsufyeva Eugenia N Preobrazhenskaya Maria N

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. : 1625-1634

Informa Healthcare

Access to resources Recommend Favorite

Oritavancin as effective as vancomycin in skin infection

Inpharma, Vol. 1, Iss. 1664, 2008-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Glycopeptide Derivatives

Current Medicinal Chemistry, Vol. 8, Iss. 14, 2001-12 ,pp. : 1759-1773

Bentham Science Publishers

Access to resources Recommend Favorite